Synnovation Therapeutics
Latest round
- Series A
Last raised
- Dec 2023
Total raised
- $15M
Investors
- 5
About Synnovation Therapeutics
Based in Delaware, US, and founded in 2021, Synnovation Therapeutics, Inc. operates as a biotechnology company. In December 2023, Synnovation Therapeutics, Inc. The company develops advanced therapeutics, diagnostics, and other solutions that have a profound impact on various aspects of human health. Synnovation specializes in precision oncology developing small molecule therapies tailored to specific cancer-driving mechanisms. Synnovation Therapeutics, Inc.
Who invested in Synnovation Therapeutics
5 investors across 1 round
See all investors in Synnovation Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 8, 2023
Amount
$15M
Investors
Questions about Synnovation Therapeutics
Who invested in Synnovation Therapeutics?
Synnovation Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synnovation Therapeutics raised?
Synnovation Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Synnovation Therapeutics last raise money?
Synnovation Therapeutics's most recent round on record is a Series A, in Dec 2023.
What does Synnovation Therapeutics do?
Based in Delaware, US, and founded in 2021, Synnovation Therapeutics, Inc.
Where is Synnovation Therapeutics headquartered?
Synnovation Therapeutics is headquartered in Wilmington, US.
Which VCs invest in companies like Synnovation Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Synnovation Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Synnovation Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.